What are the differences between abecarnil and conventional benzodiazepine anxiolytics?
Stephens, D.N.; Turski, L.; Hillman, M.; Turner, J.D.; Schneider, H.H.; Yamaguchi, M.
Advances in Biochemical Psychopharmacology 47: 395-405
1992
ISSN/ISBN: 0065-2229 PMID: 1354919 Document Number: 395323
Document emailed within 1 workday
Related Documents
Ereshefsky, L. 1984: Buspirone's advantages over benzodiazepine anxiolytics Clinical Pharmacy 3(6): 654-655Ballenger, J.C.; McDonald, S.; Noyes, R.; Rickels, K.; Sussman, N.; Woods, S.; Patin, J.; Singer, J. 1991: The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder Psychopharmacology Bulletin 27(2): 171-179
Marković, S.Z.; Dimitrijević Jovanović, N.I.; Sedić, B.; Vuković, M.H.; Okjan, J.J.; Dimitrijević, I.K.; Trikoš, L.D.; Mojović, M.š D.; Kastratović, D.A. 2019: Impact of Differences in Economic Development and Socioeconomic Stability on Benzodiazepine Exposure between the Three Balkans Countries Psychiatria Danubina 31(Suppl 5): 750-760
Guidotti, A.; Antonacci, M.D.; Giusti, P.; Massotti, M.; Memo, M.; Schlichting, J.L. 1990: The differences in the pharmacological profiles of various benzodiazepine recognition site ligands may be associated with GABAA receptor structural diversity Advances in Biochemical Psychopharmacology 46: 73-87
Andronati, S.A.; Chepelev, V.M.; Iakubovskaia, L.N.; Val'dman, A.V.; Voronina, T.A. 1983: Relationship between the structure, affinity to benzodiazepine receptors and properties of 5-halogenophenyl-1,2-dihydro-3H-1,4- benzodiazepine-2-ones Bioorganicheskaia Khimiia 9(10): 1357-1361
Sansone, M.; Castellano, C.; Pavone, F.; Hano, J. 1985: Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects Polish Journal of Pharmacology and Pharmacy 37(5): 585-590
Squires, R.F.; Klepner, C.A.; Benson, D.I. 1980: Multiple benzodiazepine receptor complexes: some benzodiazepine recognition sites are coupled to GABA receptors and ionophores Advances in Biochemical Psychopharmacology 21: 285-293
Gallager, D.W.; Wilson, M.A. 1988: Chronic benzodiazepine agonist exposure: comparison of electrophysiological changes by brain region and benzodiazepine receptor ligand Advances in Biochemical Psychopharmacology 45: 325-336
Di Braccio, M.; Roma, G.; Grossi, G.C.; Leoncini, G.; Maresca, M. 1992: 1,5-Benzodiazepines. X. Dialkylamino substituted 1,5-benzodiazepine and [1,2,4]triazolo [4,3-a][1,5] benzodiazepine derivatives with inhibitory activity on PAF-induced platelet aggregation Farmaco 47(1): 77-90
Sieghart, W.; Drexler, G.; Mayer, A.; Schuster, A. 1983: Interaction of benzodiazepine agonists and antagonists with different benzodiazepine receptors Advances in Biochemical Psychopharmacology 38: 11-19
Roma, G.; Ermili, A.; Balbi, A. 1977: Studies on 1,5-benzodiazepine. I. Derivatives of 4-amino-1,5-benzodiazepine Il Farmaco; Edizione Scientifica 32(2): 81-91
Steppuhn, K.G.; Schneider, H.H.; Turski, L.; Stephens, D.N. 1993: Long-term treatment with abecarnil does not induce diazepam-like dependence in mice Journal of Pharmacology and Experimental Therapeutics 264(3): 1395-1400
Greenblatt, D.J.; Shader, R.I. 1982: New anxiolytics: are they really new? Psychopharmacology Bulletin 18(4): 58-61
Okamura, T.; Awata, S. 2011: Anxiolytics Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 10 Pt 2: 59-63
Krause, W.; Reissmann, F.; Schunack, W.; Schöbel, C. 1991: Comparative pharmacokinetics of abecarnil in rat following single and multiple intragastric treatment and continuous administration via the diet Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(1): 29-35
Mosconi, M.; Chiamulera, C.; Recchia, G. 1993: New anxiolytics in development International Journal of Clinical Pharmacology Research 13(6): 331-344
Voronina, T.A.; Seredenin, S.B. 2002: Prospects of the search for novel anxiolytics Eksperimental'naia i Klinicheskaia Farmakologiia 65(5): 4-17
Kuwabara, H. 2012: Psychotropic drugs: Anxiolytics and hypnotics Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 25(2): 117-121
Serra, M.; Foddi, M.C.; Ghiani, C.A.; Melis, M.A.; Motzo, C.; Concas, A.; Sanna, E.; Biggio, G. 1992: Pharmacology of gamma-aminobutyric acidA receptor complex after the in vivo administration of the anxioselective and anticonvulsant beta-carboline derivative abecarnil Journal of Pharmacology and Experimental Therapeutics 263(3): 1360-1368
Marboutin, J.P.; Légeron, P.; Rivière, B. 1990: A new therapeutic approach: the behavioral prescription of anxiolytics L'Encephale 16(3): 189-196